These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1379 related articles for article (PubMed ID: 21507477)
1. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Boehme CC; Nicol MP; Nabeta P; Michael JS; Gotuzzo E; Tahirli R; Gler MT; Blakemore R; Worodria W; Gray C; Huang L; Caceres T; Mehdiyev R; Raymond L; Whitelaw A; Sagadevan K; Alexander H; Albert H; Cobelens F; Cox H; Alland D; Perkins MD Lancet; 2011 Apr; 377(9776):1495-505. PubMed ID: 21507477 [TBL] [Abstract][Full Text] [Related]
2. Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study. Dorman SE; Schumacher SG; Alland D; Nabeta P; Armstrong DT; King B; Hall SL; Chakravorty S; Cirillo DM; Tukvadze N; Bablishvili N; Stevens W; Scott L; Rodrigues C; Kazi MI; Joloba M; Nakiyingi L; Nicol MP; Ghebrekristos Y; Anyango I; Murithi W; Dietze R; Lyrio Peres R; Skrahina A; Auchynka V; Chopra KK; Hanif M; Liu X; Yuan X; Boehme CC; Ellner JJ; Denkinger CM; Lancet Infect Dis; 2018 Jan; 18(1):76-84. PubMed ID: 29198911 [TBL] [Abstract][Full Text] [Related]
3. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Steingart KR; Schiller I; Horne DJ; Pai M; Boehme CC; Dendukuri N Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD009593. PubMed ID: 24448973 [TBL] [Abstract][Full Text] [Related]
4. Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children. Kay AW; González Fernández L; Takwoingi Y; Eisenhut M; Detjen AK; Steingart KR; Mandalakas AM Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013359. PubMed ID: 32853411 [TBL] [Abstract][Full Text] [Related]
5. Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study. Scott LE; McCarthy K; Gous N; Nduna M; Van Rie A; Sanne I; Venter WF; Duse A; Stevens W PLoS Med; 2011 Jul; 8(7):e1001061. PubMed ID: 21814495 [TBL] [Abstract][Full Text] [Related]
6. Xpert MTB/RIF and Xpert Ultra assays for screening for pulmonary tuberculosis and rifampicin resistance in adults, irrespective of signs or symptoms. Shapiro AE; Ross JM; Yao M; Schiller I; Kohli M; Dendukuri N; Steingart KR; Horne DJ Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013694. PubMed ID: 33755189 [TBL] [Abstract][Full Text] [Related]
7. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Steingart KR; Sohn H; Schiller I; Kloda LA; Boehme CC; Pai M; Dendukuri N Cochrane Database Syst Rev; 2013 Jan; (1):CD009593. PubMed ID: 23440842 [TBL] [Abstract][Full Text] [Related]
8. Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults. Kohli M; Schiller I; Dendukuri N; Yao M; Dheda K; Denkinger CM; Schumacher SG; Steingart KR Cochrane Database Syst Rev; 2021 Jan; 1(1):CD012768. PubMed ID: 33448348 [TBL] [Abstract][Full Text] [Related]
9. Xpert Ultra versus Xpert MTB/RIF for pulmonary tuberculosis and rifampicin resistance in adults with presumptive pulmonary tuberculosis. Zifodya JS; Kreniske JS; Schiller I; Kohli M; Dendukuri N; Schumacher SG; Ochodo EA; Haraka F; Zwerling AA; Pai M; Steingart KR; Horne DJ Cochrane Database Syst Rev; 2021 Feb; 2():CD009593. PubMed ID: 33616229 [TBL] [Abstract][Full Text] [Related]
10. The Xpert® MTB/RIF assay in routine diagnosis of pulmonary tuberculosis: A multicentre study in Lithuania. Pimkina E; Zablockis R; Nikolayevskyy V; Danila E; Davidaviciene E Respir Med; 2015 Nov; 109(11):1484-9. PubMed ID: 26403251 [TBL] [Abstract][Full Text] [Related]
12. Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin. Pillay S; Steingart KR; Davies GR; Chaplin M; De Vos M; Schumacher SG; Warren R; Theron G Cochrane Database Syst Rev; 2022 May; 5(5):CD014841. PubMed ID: 35583175 [TBL] [Abstract][Full Text] [Related]
13. Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial. Theron G; Zijenah L; Chanda D; Clowes P; Rachow A; Lesosky M; Bara W; Mungofa S; Pai M; Hoelscher M; Dowdy D; Pym A; Mwaba P; Mason P; Peter J; Dheda K; Lancet; 2014 Feb; 383(9915):424-35. PubMed ID: 24176144 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of Xpert MTB/RIF Ultra performance for pulmonary tuberculosis diagnosis on smear-negative respiratory samples in a French centre. Hodille E; Maisson A; Charlet L; Bauduin C; Genestet C; Fredenucci I; Rasigade JP; Lina G; Dumitrescu O Eur J Clin Microbiol Infect Dis; 2019 Mar; 38(3):601-605. PubMed ID: 30680567 [TBL] [Abstract][Full Text] [Related]
15. Performance of the Xpert MTB/RIF assay in the diagnosis of tuberculosis in formalin-fixed, paraffin-embedded tissues. Polepole P; Kabwe M; Kasonde M; Tembo J; Shibemba A; O'Grady J; Kapata N; Zumla A; Bates M Int J Mycobacteriol; 2017; 6(1):87-93. PubMed ID: 28317811 [TBL] [Abstract][Full Text] [Related]
16. Assessment of the Xpert MTB/RIF assay for diagnosis of tuberculosis with gastric lavage aspirates in children in sub-Saharan Africa: a prospective descriptive study. Bates M; O'Grady J; Maeurer M; Tembo J; Chilukutu L; Chabala C; Kasonde R; Mulota P; Mzyece J; Chomba M; Mukonda L; Mumba M; Kapata N; Rachow A; Clowes P; Hoelscher M; Mwaba P; Zumla A Lancet Infect Dis; 2013 Jan; 13(1):36-42. PubMed ID: 23134697 [TBL] [Abstract][Full Text] [Related]
17. [Evaluation of the performance of InnowaveDX MTB/RIF for the detection of Wang YP; Tan YH; Li X; Wang J; Chen CG; Xu J; Xiang J Zhonghua Jie He He Hu Xi Za Zhi; 2023 Jul; 46(7):658-663. PubMed ID: 37402655 [No Abstract] [Full Text] [Related]
18. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting. Theron G; Peter J; van Zyl-Smit R; Mishra H; Streicher E; Murray S; Dawson R; Whitelaw A; Hoelscher M; Sharma S; Pai M; Warren R; Dheda K Am J Respir Crit Care Med; 2011 Jul; 184(1):132-40. PubMed ID: 21493734 [TBL] [Abstract][Full Text] [Related]
19. Effect of Introducing Xpert MTB/RIF to Test and Treat Individuals at Risk of Multidrug-Resistant Tuberculosis in Kazakhstan: A Prospective Cohort Study. van Kampen SC; Tursynbayeva A; Koptleuova A; Murzakhmetova Z; Bigalieva L; Aubakirova M; Pak S; van den Hof S PLoS One; 2015; 10(7):e0132514. PubMed ID: 26181578 [TBL] [Abstract][Full Text] [Related]
20. Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults. Horne DJ; Kohli M; Zifodya JS; Schiller I; Dendukuri N; Tollefson D; Schumacher SG; Ochodo EA; Pai M; Steingart KR Cochrane Database Syst Rev; 2019 Jun; 6(6):CD009593. PubMed ID: 31173647 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]